T cells
Pinpointing the Culprit
Pinpointing the Culprit
Rachel Berkowitz | Jun 1, 2017
Identifying immune cell subsets with CyTOF
Image of the Day: Lights, Camera, T Cells!
Image of the Day: Lights, Camera, T Cells!
The Scientist Staff | May 30, 2017
The fluid motions of a T cell’s microvilli, scanning their environment for antigens, are captured in 3-D and in real time.
Gel Scaffolds for Delivery of Immunotherapies
Gel Scaffolds for Delivery of Immunotherapies
Rachel Berkowitz | Apr 1, 2017
Using biocompatible polymers to carry cancer immune therapies directly to the tumor
Neoantigens Enable Personalized Cancer Immunotherapy
Neoantigens Enable Personalized Cancer Immunotherapy
Stephen P. Schoenberger and Ezra Cohen | Apr 1, 2017
Tumors’ mutations can encode the seeds of their own destruction, in the form of immunogenic peptides recognized by T cells.
Infographic: Targeting Cancer Antigens
Infographic: Targeting Cancer Antigens
Stephen P. Schoenberger and Ezra Cohen | Mar 31, 2017
Neoantigens may serve as valuable targets for new immunotherapies.
Mouse Immunology Paper Retracted
Mouse Immunology Paper Retracted
Jef Akst | Dec 16, 2016
A finding of misconduct spurs the retraction of a Science paper claiming to have identified a protein in mice that boosted immunity to both viruses and cancer.
Naive T Cells Find Homes in Lymphoid Tissue
Naive T Cells Find Homes in Lymphoid Tissue
Karen Zusi | Dec 2, 2016
The human lymph nodes and spleen maintain unique, compartmentalized sets of naive T cells well into old age.
Immunity in the Brain
Immunity in the Brain
Amanda B. Keener | Oct 31, 2016
Researchers document the diverse roles of immune cells in neuronal health and disease.
Study: Enriched Housing Changes Murine T Cells
Study: Enriched Housing Changes Murine T Cells
Jef Akst | Oct 3, 2016
Mice that live in a more-stimulating environment for two weeks appear to develop a more-inflammatory immune state that might help protect the animals against infection. 
CRISPR Therapy to Enter Trials
CRISPR Therapy to Enter Trials
Jef Akst | Jul 25, 2016
Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.